This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

This site is intended for UK Healthcare Professionals only

UK/FLY/2023/2543 V3 | October 2024

Prescribing information and adverse event reporting statement can be found in the footer

The Management of Sleep Disorders in Children with Neurodevelopmental Challenges

Thursday 30 March 2023 12:00 - 13:00
Join us for this online Teams meeting with our guest speaker Mr. Ibrahim Vhora. Mr Vhora will provide an update on the management of sleep disorders in children, exploring the evidence base for the pharmacological management of insomnia in children with ASD.
An account is required to register for this event.

Agenda

12:00
Introduction and welcome, Connor Marchbank, Engagement Specialist, Flynn Pharma Limited
12:05
The management of sleep disorders in children with neurodevelopmental challenges, Mr. Ibrahim Vhora, Lead Pharmacist Neurodevelopmental Paediatrics, Alder Hey Children's NHS Foundation Trust
12:45
Questions and discussion, Mr. Ibrahim Vhora, Lead Pharmacist Neurodevelopmental Paediatrics, Alder Hey Children's NHS Foundation Trust
13:00
Meeting close

Meet the Speakers

Mr. Ibrahim Vhora
Mr. Ibrahim Vhora
Lead Pharmacist Neurodevelopmental Paediatrics, Alder Hey Children’s NHS Foundation Trust

Ibrahim Vhora graduated at the Leicester school of pharmacy in 2013 and subsequently trained at
Alder Hey Children’s hospital as a specialist paediatric clinical pharmacist. Whilst working at Alder Hey, Ibrahim has gained extensive experience in the field of paediatric pharmacy and held a variety of positions, including medicines information, clinical trials, formulary and procurement. More recently he has specialised in developmental paediatrics and has a particular interest in Autism Spectrum Disorder, ADHD and insomnia, in which he has completed sleep practitioner training. He is passionate about using medicines appropriately and in particular, the overuse of medicine. Ibrahim specialises in medicines management, governance, medication safety and medicines optimisation.

Whilst in role, Ibrahim has led on service development, with a focus on digital improvement. He has also worked closely with, and developed relationships across, clinical commissioning groups (CCGs), and clinical supporting units (CSUs) in order to improve the care interface. A focus of development is sleep pathways within Alder Hey and collaborating with other trusts within Merseyside to unify practice. He is leading on a pilot which evaluates the effect of behavioural sleep intervention on the resolution of sleeping difficulties and subsequent medication use.

What will the webinar cover?

Key learning objectives

  • To provide an update on the management of sleep disorders in children, exploring the evidence base for the pharmacological management of insomnia in children with ASD